These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mechanisms and management of cough in interstitial lung disease. Rasheed AZ; Metersky ML; Ghazal F Expert Rev Respir Med; 2023 Dec; 17(12):1177-1190. PubMed ID: 38159067 [TBL] [Abstract][Full Text] [Related]
4. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases. Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic and Nonpharmacologic Treatment for Acute Cough Associated With the Common Cold: CHEST Expert Panel Report. Malesker MA; Callahan-Lyon P; Ireland B; Irwin RS; Chest; 2017 Nov; 152(5):1021-1037. PubMed ID: 28837801 [TBL] [Abstract][Full Text] [Related]
6. Chronic cough due to chronic interstitial pulmonary diseases: ACCP evidence-based clinical practice guidelines. Brown KK Chest; 2006 Jan; 129(1 Suppl):180S-185S. PubMed ID: 16428708 [TBL] [Abstract][Full Text] [Related]
7. What causes cough in pulmonary fibrosis, and how should we treat it? Myall KJ; Cho PSP; Birring SS Curr Opin Pulm Med; 2024 Sep; 30(5):523-529. PubMed ID: 38913018 [TBL] [Abstract][Full Text] [Related]
8. [Expert consensus on the management of interstitial lung disease during the COVID-19 epidemic]. Respiratory Council of Chinese Research Hospital Association Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1204-1218. PubMed ID: 38044048 [TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease. Lalloo UG; Lim S; DuBois R; Barnes PJ; Chung KF Eur Respir J; 1998 Mar; 11(3):702-5. PubMed ID: 9596124 [TBL] [Abstract][Full Text] [Related]
10. Cough in interstitial lung disease. Garner J; George PM; Renzoni E Pulm Pharmacol Ther; 2015 Dec; 35():122-8. PubMed ID: 26545874 [TBL] [Abstract][Full Text] [Related]
11. Antitussive Effect of a Chest Band in Patients with Interstitial Lung Disease: The Preliminary Results from a Pre-post Intervention Study. Sato R; Handa T; Matsumoto H; Hirai K; Ohkura N; Kubo T; Hirai T Intern Med; 2021; 60(23):3701-3707. PubMed ID: 34853257 [TBL] [Abstract][Full Text] [Related]
12. Assessment of Intervention Fidelity and Recommendations for Researchers Conducting Studies on the Diagnosis and Treatment of Chronic Cough in the Adult: CHEST Guideline and Expert Panel Report. French CT; Diekemper RL; Irwin RS; Adams TM; Altman KW; Barker AF; Birring SS; Blackhall F; Bolser DC; Boulet LP; Braman SS; Brightling C; Callahan-Lyon P; Canning BJ; Chang AB; Coeytaux R; Cowley T; Davenport P; Diekemper RL; Ebihara S; El Solh AA; Escalante P; Feinstein A; Field SK; Fisher D; French CT; Gibson P; Gold P; Gould MK; Grant C; Harding SM; Harnden A; Hill AT; Irwin RS; Kahrilas PJ; Keogh KA; Lane AP; Lim K; Malesker MA; Mazzone P; Mazzone S; McCrory DC; McGarvey L; Molasiotis A; Murad MH; Newcombe P; Nguyen HQ; Oppenheimer J; Prezant D; Pringsheim T; Restrepo MI; Rosen M; Rubin B; Ryu JH; Smith J; Tarlo SM; Vertigan AE; Wang G; Weinberger M; Weir K; Chest; 2015 Jul; 148(1):32-54. PubMed ID: 25764280 [TBL] [Abstract][Full Text] [Related]
13. Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Guideline and Expert Panel Report. Côté A; Russell RJ; Boulet LP; Gibson PG; Lai K; Irwin RS; Brightling CE; Chest; 2020 Jul; 158(1):68-96. PubMed ID: 31972181 [TBL] [Abstract][Full Text] [Related]
15. Association of progressive systemic sclerosis with pulmonary sarcoidosis. Just a chance occurrence? Takahashi T; Munakata M; Homma Y; Kawakami Y Intern Med; 1997 Jun; 36(6):435-8. PubMed ID: 9213193 [TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil as a therapeutic agent for interstitial lung diseases in systemic sclerosis. Ueda T; Sakagami T; Kikuchi T; Takada T Respir Investig; 2018 Jan; 56(1):14-20. PubMed ID: 29325675 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of self-reported cough intensity and frequency in patients with interstitial lung disease: a cross-sectional study. Sato R; Handa T; Matsumoto H; Kubo T; Hirai T BMC Pulm Med; 2019 Dec; 19(1):247. PubMed ID: 31842848 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial. Gao R; Xu X; Wang S; Pu J; Shi C; Wen S; Zhu Y; Tang J; Wang X; Yu L Trials; 2022 Feb; 23(1):165. PubMed ID: 35189953 [TBL] [Abstract][Full Text] [Related]
19. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial. Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061 [TBL] [Abstract][Full Text] [Related]
20. A case report: The efficacy of pirfenidone in a Chinese patient with progressive systemic sclerosis-associated interstitial lung disease: A CARE-compliant article. Huang H; Feng RE; Li S; Xu K; Bi YL; Xu ZJ Medicine (Baltimore); 2016 Jul; 95(27):e4113. PubMed ID: 27399114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]